| 1 |
Weekly Paclitaxel given concurrently with Durvalumab has a favorable safety profile in triple-negative metastatic breast cancer |
|
| | Hazem Ghebeh, Adher Al-Sayed, Riham Eiada, Leilani Cabangon, Dahish Ajarim, Kausar Suleman, Asma Tulbah, Taher Al-Tweigeri | | | Scientific Reports. 2021; 11(1) | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Dermatologic adverse effects of breast cancer chemotherapy: a longitudinal prospective observational study with a review of literature |
|
| | Narges Alizadeh, Seyyed Hossein Mirpour, Abbas Darjani, Rana Rafiei, Elahe Rafiei, Maryam Mohammadhoseini | | | International Journal of Dermatology. 2020; 59(7): 822 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Cytostatic and cytotoxic drugs |
|
| | Gupta, A., Middleton, M. | | | Side Effects of Drugs Annual. 2011; 33(1): 935-962 | | | [Pubmed] [Google Scholar] | | | 4 |
Screening of some plant extracts against some skin diseases caused by oxidative stress and microorganisms |
|
| | Chanda, S., Baravalia, Y. | | | African Journal of Biotechnology. 2010; 9(21): 3210-3217 | | | [Pubmed] [Google Scholar] | |
|
